We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+4.7%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$72.6B
AUM Growth
+$7.53B
Cap. Flow
+$3.73B
Cap. Flow %
5.13%
Top 10 Hldgs %
9.55%
Holding
3,940
New
507
Increased
1,441
Reduced
1,273
Closed
394

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$434M
2
NFLX icon
Netflix
NFLX
+$301M
3
BABA icon
Alibaba
BABA
+$245M
4
VZ icon
Verizon
VZ
+$235M
5
TSLA icon
Tesla
TSLA
+$230M

Sector Composition

Rank Sector Weight
1 Technology 13.95%
2 Healthcare 11.57%
3 Consumer Discretionary 9.23%
4 Communication Services 8.8%
5 Industrials 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WIN
3476
CALL
DELISTED
Windstream Holdings Inc
WIN
$65K ﹤0.01%
7,040
STLRW
3477
DELISTED
Stellar Acquisition III Inc. Warrants
STLRW
$64K ﹤0.01%
205,000
SGY.WS
3478
DELISTED
Stone Energy Corporation Warrants to purchase common stock (expiring February 28, 2021)
SGY.WS
$64K ﹤0.01%
12,800
NVAX icon
3479
CALL
Novavax
NVAX
$1.45B
$62K ﹤0.01%
2,500
CASC
3480
DELISTED
Cascadian Therapeutics, Inc.
CASC
$62K ﹤0.01%
16,846
+2,400
+17% +$9.83K
ELDN icon
3481
Eledon Pharmaceuticals
ELDN
$274M
$61K ﹤0.01%
871
ALTO icon
3482
Alto Ingredients
ALTO
$324M
$60K ﹤0.01%
13,133
-1,180
-8% -$5.59K
AGTC
3483
DELISTED
Applied Genetic Technologies Corporation
AGTC
$58K ﹤0.01%
+15,990
New +$60.4K
ADXS
3484
CALL
DELISTED
Advaxis Inc
ADXS
$57K ﹤0.01%
1,333
BRACR
3485
DELISTED
Black Ridge Acquisition Corp. Right
BRACR
$57K ﹤0.01%
+203,900
New +$56.7K
IBRX icon
3486
ImmunityBio
IBRX
$8.07B
$54K ﹤0.01%
+12,028
New +$57K
AVXL icon
3487
Anavex Life Sciences
AVXL
$289M
$52K ﹤0.01%
+16,140
New +$63.5K
BRACW
3488
DELISTED
Black Ridge Acquisition Corp. Warrant
BRACW
$49K ﹤0.01%
+147,449
New +$42.2K
WLB
3489
DELISTED
Westmoreland Coal Company
WLB
$47K ﹤0.01%
38,455
-64,668
-63% -$111K
MMDMW
3490
DELISTED
Modern Media Acquisition Corp. Warrant
MMDMW
$45K ﹤0.01%
89,000
MMDMR
3491
DELISTED
Modern Media Acquisition Corp. Right
MMDMR
$45K ﹤0.01%
115,300
SRNE
3492
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$42K ﹤0.01%
+11,000
New +$28.7K
SMRT
3493
DELISTED
Stein Mart Inc
SMRT
$41K ﹤0.01%
35,377
+12,181
+53% +$14.1K
ANTH
3494
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$41K ﹤0.01%
+24,606
New +$42.3K
BCIC
3495
BCP Investment Corp
BCIC
$95.1M
$35K ﹤0.01%
1,041
RGLS
3496
DELISTED
Regulus Therapeutics
RGLS
$28K ﹤0.01%
228
-20
-8% -$2.53K
GST
3497
DELISTED
Gastar Exploration Inc.
GST
$25K ﹤0.01%
23,963
-4,600
-16% -$4K
ARQL
3498
DELISTED
Arqule Inc
ARQL
$22K ﹤0.01%
13,624
-687,474
-98% -$891K
MVIS icon
3499
Microvision
MVIS
$52M
$21K ﹤0.01%
859
-551
-39% -$15.9K
SDRL
3500
DELISTED
Seadrill Limited Common Stock
SDRL
$3K ﹤0.01%
41

Similar funds

David Shaw's Q4 2017 Portfolio in Review

As of Q4 2017, David Shaw held 3,940 positions worth $72.6B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

David Shaw deployed $3.73B of net new capital in Q4 2017, opening 507 new positions and adding to 1,441 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $434M trimmed.

  • David Shaw's largest Q4 2017 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
  • David Shaw added most to GE Aerospace in Q4 2017, an estimated $570M increase.
  • David Shaw's biggest Q4 2017 reduction was Apple, cutting an estimated $434M.
  • David Shaw fully exited Tesla in Q4 2017, selling an estimated $230M.
  • David Shaw's ten largest holdings make up 9.5% of its $72.6B portfolio in Q4 2017.
  • David Shaw opened 507 new positions and closed 394 in Q4 2017.
  • David Shaw's portfolio value rose 12% quarter-over-quarter to $72.6B.

Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.